Wedbush upgraded Rezolute (RZLT) to Outperform from Neutral with a price target of $5, up from $2.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RZLT:
- Rezolute Prepares FDA Submission After sunRIZE Trial Review
- Rezolute provides update on sunRIZE study following Type B meeting with FDA
- Rezolute management to meet with Maxim
- Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
- Rezolute reports Q2 EPS (22c), consensus (18c)